Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention
Gilead’s recently approved drug for HIV prevention, Yeztugo (lenacapavir), has the potential to transform the pre-exposure prophylaxis (PrEP) sector in …
Post
-
-
Sanofi agrees to invest $25m in Adagene
Sanofi has agreed to invest up to $25m in Adagene, which will enable the latter to fund its research and …
-
Trump tax bill estimated to cut Medicaid spend by $1trn passes US Senate
US President Donald Trump’s One Big Beautiful Bill Act (H.R. 1) has narrowly passed after US Vice President JD Vance …
-
Vertex wins European approval for Alyftrek, bolstering cystic fibrosis stronghold
Vertex Pharmaceuticals has won approval in Europe for its next-generation cystic fibrosis therapy Alyftrek (deutivacaftor/tezacaftor/vanzacaftor), shoring up the company’s dominance …
-
Merck concludes SpringWorks acquisition for $3.4bn
Merck KGaA has concluded the previously announced acquisition of SpringWorks Therapeutics for an enterprise value of €3bn ($3.4bn), after receiving …
-
Cell and gene therapy: The vital role of logistics
Cell and gene therapies (CGT) offer hope to patients living with life-threatening conditions where limited treatment options may be available …
-
Uruguay progresses towards developing its first regulatory agency
Uruguay’s new left-wing coalition government took office in March 2025, under President Yamandu Orsi. Part of his new agenda has …
-
EC approves Jazz Pharmaceuticals’ Ziihera for biliary tract cancer
Jazz Pharmaceuticals has received conditional marketing authorisation from the European Commission (EC) for its new bispecific antibody, Ziihera (zanidatamab), for …
-
Oncternal sells assets for up to $68m and calls it quits
American oncology company Oncternal Therapeutics is to wind down operations after announcing the sale of its main drug programmes. Delaware-based Ho’ola …
-
Sanofi’s riliprubart gains ODD status from Japan’s MHLW for CIDP
Sanofi's antibody riliprubart has received orphan drug designation (ODD) from Japan's Ministry of Health, Labour and Welfare (MHLW) for its …
-
EU’s Pharma Package falls short of Europe’s goal of global competitiveness
In a bid to chase competitiveness, the EU is advancing its most drastic revision of pharmaceutical law in 20 years. …
-
AbbVie buys $2.1bn Capstan, adding new in vivo CAR-T to pipeline
AbbVie has agreed to acquire Capstan Therapeutics for up to $2.1bn, adding a “high-risk, high-reward” clinical-stage in vivo CAR-T candidate …
-
Piramal Pharma announces $90m investment to expand US sites
Piramal Pharma Solutions has announced an investment of $90m to expand its two US facilities, enhancing manufacturing capabilities for sterile …
-
FDA approves Takeda’s Gammagard liquid ERC for primary immunodeficiency
The US Food and Drug Administration (FDA) has approved Takeda’s new immunoglobulin (IG) therapy, Gammagard liquid ERC [immune globulin infusion …
-
WHO accuses China of withholding Covid-19 genetic data
The World Health Organization (WHO) says it is unable to concretely identify the origins of the virus that led to …
